Wenger, Nikolaus
Moraud, Eduardo Martin
Gandar, Jerome
Musienko, Pavel
Capogrosso, Marco
Baud, Laetitia
Le Goff, Camille G
Barraud, Quentin
Pavlova, Natalia
Dominici, Nadia
Minev, Ivan R
Asboth, Leonie
Hirsch, Arthur
Duis, Simone
Kreider, Julie
Mortera, Andrea
Haverbeck, Oliver
Kraus, Silvio
Schmitz, Felix
DiGiovanna, Jack
van den Brand, Rubia
Bloch, Jocelyne
Detemple, Peter
Lacour, Stéphanie P
Bézard, Erwan
Micera, Silvestro
Courtine, Grégoire
Article History
Received: 24 December 2014
Accepted: 8 December 2015
First Online: 18 January 2016
Competing interests
: G.C., N.W., P.M., M.C., L.A., J.B., I.R.M., E.M.M., S.M. and S.P.L. hold various patents on electrode implant designs (WO2011/157714), chemical neuromodulation therapies (WO2015/000800), spatiotemporal neuromodulation algorithms (WO2015/063127), and robot-assisted rehabilitation enabled by neuromodulation therapies (WO2013/179230). G.C., S.L., S.M. and J.B. are founders and shareholders of G-Therapeutics SA, a company developing neuroprosthetic systems in direct relationship with the present work.